FI922582L - Fettsyrabehandling - Google Patents

Fettsyrabehandling Download PDF

Info

Publication number
FI922582L
FI922582L FI922582A FI922582A FI922582L FI 922582 L FI922582 L FI 922582L FI 922582 A FI922582 A FI 922582A FI 922582 A FI922582 A FI 922582A FI 922582 L FI922582 L FI 922582L
Authority
FI
Finland
Prior art keywords
fatty acid
acid treatment
treatment
fatty
acid
Prior art date
Application number
FI922582A
Other languages
English (en)
Finnish (fi)
Other versions
FI922582A0 (fi
FI922582A7 (fi
Inventor
David Frederick Horrobin
Alfred Colin Buck
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of FI922582A0 publication Critical patent/FI922582A0/fi
Publication of FI922582A7 publication Critical patent/FI922582A7/fi
Publication of FI922582L publication Critical patent/FI922582L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI922582A 1991-06-05 1992-06-04 Fettsyrabehandling FI922582L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919112052A GB9112052D0 (en) 1991-06-05 1991-06-05 Fatty acid treatment

Publications (3)

Publication Number Publication Date
FI922582A0 FI922582A0 (fi) 1992-06-04
FI922582A7 FI922582A7 (fi) 1992-12-06
FI922582L true FI922582L (fi) 1992-12-06

Family

ID=10696108

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922582A FI922582L (fi) 1991-06-05 1992-06-04 Fettsyrabehandling

Country Status (14)

Country Link
US (1) US5318991A (https=)
EP (1) EP0517425A1 (https=)
JP (1) JPH05178744A (https=)
KR (1) KR930000114A (https=)
AU (1) AU659456B2 (https=)
CA (1) CA2070468A1 (https=)
FI (1) FI922582L (https=)
GB (1) GB9112052D0 (https=)
IE (1) IE921806A1 (https=)
NO (1) NO302100B1 (https=)
NZ (1) NZ242897A (https=)
SG (1) SG49682A1 (https=)
TW (1) TW200397B (https=)
ZA (1) ZA923915B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516801A (en) * 1992-08-21 1996-05-14 Scotia Holdings Plc Fatty acid treatment for ectopic calcium deposition
GB9217780D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
GB9217781D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
US5888541A (en) * 1992-08-21 1999-03-30 Scotia Holdings Plc Fatty acid treatment
AU683027B2 (en) * 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
FR2704390B1 (fr) * 1993-04-29 1995-06-02 Boiron Complément nutritionnel absorbable per-os destiné à améliorer la peau.
DE69326949T2 (de) * 1993-08-20 2000-02-17 Societe Des Produits Nestle S.A., Vevey Lipidzusammensetzung für Nahrungsmittel
US5668174A (en) * 1993-12-29 1997-09-16 Kowa Tekuno Sachi Co., Ltd. Method of treating hyperparathyroidism
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
US5804210A (en) * 1996-08-07 1998-09-08 Wisconsin Alumni Research Foundation Methods of treating animals to maintain or enhance bone mineral content and compositions for use therein
WO1999003456A2 (en) * 1997-07-16 1999-01-28 Societe Des Produits Nestle S.A. Method for prophylaxis or treatment of bone density loss
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
ES2289097T3 (es) * 2001-03-15 2008-02-01 Dsm Ip Assets B.V. Composicion para la prevencion de la osteoporosis consistente de una combinacion de isoflavonas y acidos grasos poliinsaturados.
US6576667B2 (en) * 2001-11-14 2003-06-10 Norel Acquisition Corp. Method for manufacturing fatty acid calcium salts from high glyceride content oils
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US8728546B1 (en) 2013-03-15 2014-05-20 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer, cardiovascular diseases and inflammation
US9682055B2 (en) 2014-06-04 2017-06-20 Dignity Sciences Limted Pharmaceutical compositions comprising DGLA and use of same
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1417119A (en) * 1972-11-30 1975-12-10 Thiele G H Process for treating bones
EP0150248B1 (de) * 1984-02-01 1988-10-19 T P O "Pharmachim" Mittel zur Behandlung und Prophylaxe uratischer und gemischter uratischer Lithiasis
GB8621816D0 (en) * 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
JPH0625057B2 (ja) * 1987-12-14 1994-04-06 日本油脂株式会社 骨形成促進剤
US4855736A (en) * 1988-06-03 1989-08-08 Hsu Chi Heng Electronic parking sensor apparatus
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
GB9001121D0 (en) * 1990-01-18 1990-03-21 Efamol Holdings Efa compositions and therapy
GB9002048D0 (en) * 1990-01-30 1990-03-28 Efamol Holdings Essential fatty acid compositions and treatments

Also Published As

Publication number Publication date
TW200397B (https=) 1993-02-21
AU1726692A (en) 1992-12-10
FI922582A0 (fi) 1992-06-04
US5318991A (en) 1994-06-07
KR930000114A (ko) 1993-01-15
NZ242897A (en) 1997-06-24
IE921806A1 (en) 1992-12-16
GB9112052D0 (en) 1991-07-24
CA2070468A1 (en) 1992-12-06
NO302100B1 (no) 1998-01-26
SG49682A1 (en) 1998-06-15
ZA923915B (en) 1993-02-24
EP0517425A1 (en) 1992-12-09
NO922214D0 (no) 1992-06-04
FI922582A7 (fi) 1992-12-06
AU659456B2 (en) 1995-05-18
JPH05178744A (ja) 1993-07-20
NO922214L (no) 1992-12-07

Similar Documents

Publication Publication Date Title
FI912703A7 (fi) Oleellinen rasvahappokäsittely
FI940642L (fi) Imidatsolyyli-alkeenihapot
NO934726D0 (no) (S)(+)-2-etoksy-4-ÚN-Ú1-(2-piperidinofenyl)-3-metyl-1-butyl¾amin okarbonylmetyl¾-benzoesyre
FI922542L (fi) Fettsyrakompositioner
FI930387A7 (fi) Stabiili hoitoshampoo, joka sisältää rasvahappoa
DE69124516D1 (de) Katheter
DE69215639D1 (de) Endoskop
FI922953A7 (fi) 7-azaisoindolinylkinolon- och naftyridonkarboxylsyraderivat
FI922582A7 (fi) Rasvahappokäsittely
FI922873A7 (fi) 7-isoindolinyl-kinolon- och -naftyridonkarboxylsyraderivat
FI921163A7 (fi) N-acyl-a-aminosyraderivat
FI925000A7 (fi) Hjaernmagnetograf
DK0464381T3 (da) 2-Methoximinocarboxylsyreestere
FI924570A7 (fi) Bentsimidatsolifosfonoaminohappoja
FI904403A7 (fi) Rasvahappohoito
DK73891D0 (da) Enzymbehandling
FI924355L (fi) Substituerade imidazolylpropensyraderivat
DE59207354D1 (de) Triazinyl-substituierte Acrylsäureester
DE59305938D1 (de) Pyridyloxy-acrylsäureester
FI924354A7 (fi) Imidatsolyylipropeenihappojohdannaisia
FI925469A7 (fi) Tiatsolyylillä substituoidut kinolyylimetoksifenyylietikkahappojohdannaiset
DE59205221D1 (de) 1-Alkoxyhexatrien-2-carbonsäureester
DK373688A (da) Behandlingsmetode
FI922125L (fi) Mikrobidogiskt foerfarande foer framstaellning av 5-hydroxipyrazinkarboxylsyra
FI934222A7 (fi) Pyridatsinonietikkahappoja

Legal Events

Date Code Title Description
FD Application lapsed